Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk

Table 4

Frequency of subjects with cardiovascular risk factors in SCH PCOS, euthyroid PCOS, and euthyroid control subjects.

	SCH PCOS; ()	Euthyroid PCOS; ()	Euthyroid control; ()	value
Hypertension (%)	7 (25.9)	11 (16.17)	5 (5.5)	0.008
Insulin resistance (HOMA-IR >2.0)	27 (100)	38 (56)	15 (16.48)	<0.0001
Dyslipidemia	24 (89)	31 (45.5)	13 (14.2)	<0.0001

⁢ = NS between SCH PCOS and euthyroid PCOS, between SCH PCOS and euthyroid controls, and between euthyroid PCOS and euthyroid control group.
⁢ between SCH PCOS and euthyroid PCOS group, between SCH PCOS and euthyroid controls, and between euthyroid PCOS and euthyroid control group on post hoc analysis.